[The effect of trasylol in thioacetamide-induced liver damage of the rat].
D000577:Amides; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D007611:Aprotinin / Q000494:pharmacology* / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood*; D056486:Chemical and Drug Induced Liver Injury; D003168:Complement Fixation Tests; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D008107:Liver Diseases / Q000188:drug therapy / Q000201:enzymology* / Q000276:immunology*; D008297:Male; D051381:Rats; D013438:Sulfhydryl Compounds
D000577:Amides; D013438:Sulfhydryl Compounds; D007611:Aprotinin; D001219:Aspartate Aminotransferases
Die Wirkung des Trasylols bei der Thioacetamid-induzierten Leberschädigung der Ratte.